We were delighted to welcome George Freeman MP, the Parliamentary under Secretary of State in the Department for Business, Energy and Industrial Strategy, for a visit to the Milner Therapeutics Institute last week. Mr Freeman met with MTI Directors Tony Kouzarides and Kathryn Chapman, as well as Jason Mellad of Start Codon to witness first-hand the success of their model for academic-industry collaborations, acceleration of spin-out companies, and role in the University Connect: Health Tech online community networking platform.

The visit to the Cambridge Biomedical Campus (CBC) followed the site’s delegation as a Life Sciences Opportunity Zone, and allowed the Minister to learn how Cambridge is home to one of the strongest health and life science clusters dedicated to improving people’s lives.

Science and Innovation Minister George Freeman said:

“During my lifetime in and around Cambridge I’ve seen the Cambridge science and technology cluster grow into a global powerhouse of innovation in biomedical and digital technologies.

 

“As UK Science and Innovation Minister, my core mission is to ensure we continue to support this cluster with continued investment in great science and infrastructure for better connectivity to spread opportunities across the Eastern region, and learn the lessons from Cambridge to help grow the other emerging clusters around the whole of the UK.

 

“Bringing the kind of high-tech jobs and economic prosperity Cambridge has enjoyed to other parts of the UK is key to our Levelling Up commitment, and thanks to the work being done here we have an excellent blueprint to put the infrastructure in place to make that happen. Cambridge has shown what’s possible.

 

“As we move the UK from a service economy to an innovation economy I look forward to continuing our work with researchers and businesses here to help innovative companies in Cambridge go from strength to strength, while growing similar clusters across the UK.”

 

Read the full press release from the Cambridge Biomedical Campus at this link.

MILNER THERAPEUTICS SYMPOSIUM

X